Cargando…

Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial()()

BACKGROUND: Observational studies have suggested a higher risk of thrombotic events in patients with coronavirus disease 2019 (COVID-19). Moreover, elevated D-dimer levels have been identified as an important prognostic marker in COVID-19 directly associated with disease severity and progression. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopes, Renato D., de Barros e Silva, Pedro Gabriel Melo, Furtado, Remo H.M., Macedo, Ariane Vieira Scarlatelli, Ramacciotti, Eduardo, Damini, Lucas Petri, Bronhara, Bruna, Cavalcanti, Alexandre B., Rosa, Regis G., Azevedo, Luciano C.P., Veiga, Viviane C., Machado, Flávia R, Ritt, Luiz Eduardo, Martins, Priscilla de Aquino, Alexander, John H., Avezum, Alvaro, Berwanger, Otavio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Trial Designs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057688/ https://www.ncbi.nlm.nih.gov/pubmed/33891907 http://dx.doi.org/10.1016/j.ahj.2021.04.005

Ejemplares similares

The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges
por: Eikelboom, John, et al.
Publicado: (2022)

On Menstrual Coagula
por: Haddon, John
Publicado: (1872)

Fibrinous Coagula in the Heart
por: Roy, G. C.
Publicado: (1883)

On Emboli, and Cardiac Coagula
por: Orr, R. Scott
Publicado: (1869)

On Intrauterine Puerperal Coagula
por: Duncan, J. Matthews
Publicado: (1880)

Fibrinous Coagula in the Heart
Publicado: (1864)

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs
por: Thompson, Jennifer A, et al.
Publicado: (2017)

The Formation of Coagula in the Circulatory System
por: Holmes, E. L.
Publicado: (1861)

The development and description of the comparison group in the Look AHEAD trial
Publicado: (2011)

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer
por: Brown, Louise C, et al.
Publicado: (2022)

Redesigning a large school-based clinical trial in response to changes in community practice
por: Gerald, Lynn B, et al.
Publicado: (2011)

Randomized trials of alcohol-use interventions with college students and their parents: lessons from the Transitions Project
por: Fernandez, AC, et al.
Publicado: (2011)

EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country
por: Mooney, Thomas, et al.
Publicado: (2018)

Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom
por: Török, M Estée, et al.
Publicado: (2021)

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C
por: Reddy, K Rajender, et al.
Publicado: (2012)

Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study
por: Connor, Jason T, et al.
Publicado: (2013)

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
por: Longini, Ira M, et al.
Publicado: (2022)

A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen
por: Fiore, Louis D, et al.
Publicado: (2011)

Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic
por: Madewell, Zachary J, et al.
Publicado: (2021)

Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak
por: Edwards, Tansy, et al.
Publicado: (2016)

Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2008)

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless phase II/III design
por: Levin, Bruce, et al.
Publicado: (2011)

Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial()
por: Ramacciotti, Eduardo, et al.
Publicado: (2021)

The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2019)

Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov
por: Calvocoressi, Lisa, et al.
Publicado: (2020)

Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)
por: Becher, Marc Ulrich, et al.
Publicado: (2021)

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018)

A Randomized Controlled Trial Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation in the General Population: E3 Trial Design
por: Hébert-Losier, Andréa, et al.
Publicado: (2020)

A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: The ADVENT trial rationale and design
por: Reddy, Vivek Y., et al.
Publicado: (2023)

From hybrid to fully remote clinical trial amidst the COVID-19 pandemic: Strategies to promote recruitment, retention, and engagement in a randomized mHealth trial
por: Simmons, Leigh Ann, et al.
Publicado: (2022)

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
por: Farrant, John, et al.
Publicado: (2023)

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT‐AF/VTE)—Trial design
por: Colonna, Paolo, et al.
Publicado: (2018)

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
por: Bhatt, Deepak L., et al.
Publicado: (2017)

Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial
por: Tajstra, Mateusz, et al.
Publicado: (2023)

Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial)
por: Palau, Patricia, et al.
Publicado: (2020)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
por: Sadeghi, Masoumeh, et al.
Publicado: (2020)

Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease
por: Ripley, David P., et al.
Publicado: (2015)

Rationale and design of the OPTIMAL‐REPERFUSION trial: A prospective randomized multi‐center clinical trial comparing different fibrinolysis‐transfer percutaneous coronary intervention strategies in acute ST‐segment elevation myocardial infarction
por: Chen, Zhongxiu, et al.
Publicado: (2021)

A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
por: Hayer, Manvir K., et al.
Publicado: (2017)

Evaluating the safety of a rotavirus vaccine: the REST of the story
por: Heyse, Joseph F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_moj3g234so5drueva9e6i1ihv3